IL67686A - 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinones,their preparation and pharmaceutical compositions containing them - Google Patents

3-(1h-tetrazol-5-yl)-4(3h)-quinazolinones,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL67686A
IL67686A IL67686A IL6768683A IL67686A IL 67686 A IL67686 A IL 67686A IL 67686 A IL67686 A IL 67686A IL 6768683 A IL6768683 A IL 6768683A IL 67686 A IL67686 A IL 67686A
Authority
IL
Israel
Prior art keywords
tetrazol
quinazolinones
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL67686A
Other languages
English (en)
Other versions
IL67686A0 (en
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of IL67686A0 publication Critical patent/IL67686A0/xx
Publication of IL67686A publication Critical patent/IL67686A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Adhesive Tapes (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Materials For Photolithography (AREA)
IL67686A 1982-01-18 1983-01-14 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinones,their preparation and pharmaceutical compositions containing them IL67686A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/340,577 US4419357A (en) 1982-01-18 1982-01-18 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones

Publications (2)

Publication Number Publication Date
IL67686A0 IL67686A0 (en) 1983-05-15
IL67686A true IL67686A (en) 1985-12-31

Family

ID=23333997

Family Applications (1)

Application Number Title Priority Date Filing Date
IL67686A IL67686A (en) 1982-01-18 1983-01-14 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinones,their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US4419357A (no)
EP (1) EP0086340B1 (no)
JP (1) JPS58124783A (no)
KR (1) KR880002358B1 (no)
AT (1) ATE18908T1 (no)
AU (2) AU555629B2 (no)
CA (1) CA1254204A (no)
DE (1) DE3362735D1 (no)
DK (1) DK159271C (no)
ES (1) ES8501758A1 (no)
GB (2) GB2113220B (no)
GR (1) GR77393B (no)
IE (1) IE54441B1 (no)
IL (1) IL67686A (no)
NO (1) NO830115L (no)
NZ (1) NZ203034A (no)
PH (1) PH18222A (no)
ZA (1) ZA83240B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4644065A (en) * 1984-05-15 1987-02-17 Merrell Dow Pharmaceuticals Inc. Process for the preparation of 4(3H)-quinazolinones
GB8429739D0 (en) * 1984-11-24 1985-01-03 Fbc Ltd Fungicides
US4761474A (en) * 1986-02-25 1988-08-02 Merrell Dow Pharmaceuticals Inc. 3-(1H-tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones
US4757075A (en) * 1986-10-14 1988-07-12 Merrell Dow Pharmaceuticals Inc. Tetrazolylquinazolinones as anti-hyperuricemic agents
US8975288B2 (en) 2012-04-10 2015-03-10 The Penn State Research Foundation F2 derivatives as antibacterial agents
CA2871271A1 (en) * 2012-04-27 2013-06-13 Basf Se Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH364040A (fr) * 1960-04-19 1962-08-31 Ipa Anstalt Dispositif de détection pour vérifier si un élément d'une installation électrique est sous tension
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds
GB1561350A (en) * 1976-11-05 1980-02-20 May & Baker Ltd Benzamide derivatives
AU508970B2 (en) * 1976-02-13 1980-04-17 Bristol-Myers Company Tetrazole derivatives
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
US4209620A (en) * 1978-06-19 1980-06-24 Bristol-Myers Company Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
GB2095240A (en) * 1981-03-05 1982-09-29 Fujisawa Pharmaceutical Co Dihydropyrimidine derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones

Also Published As

Publication number Publication date
GB8428402D0 (en) 1984-12-19
AU1037783A (en) 1983-07-28
GB2113220B (en) 1985-09-04
EP0086340B1 (en) 1986-04-02
DK159271B (da) 1990-09-24
JPH0450310B2 (no) 1992-08-13
IE830078L (en) 1983-07-18
ATE18908T1 (de) 1986-04-15
GB2170800A (en) 1986-08-13
KR840003250A (ko) 1984-08-20
AU570852B2 (en) 1988-03-24
EP0086340A1 (en) 1983-08-24
GB2113220A (en) 1983-08-03
DK16783D0 (da) 1983-01-17
CA1254204A (en) 1989-05-16
NO830115L (no) 1983-07-19
ES519005A0 (es) 1984-12-16
AU6151786A (en) 1986-12-11
GR77393B (no) 1984-09-11
NZ203034A (en) 1985-09-13
KR880002358B1 (ko) 1988-10-29
ES8501758A1 (es) 1984-12-16
GB8300957D0 (en) 1983-02-16
PH18222A (en) 1985-04-30
US4419357A (en) 1983-12-06
JPS58124783A (ja) 1983-07-25
GB2170800B (en) 1987-01-07
DE3362735D1 (de) 1986-05-07
DK159271C (da) 1991-02-18
IE54441B1 (en) 1989-10-11
AU555629B2 (en) 1986-10-02
DK16783A (da) 1983-07-19
ZA83240B (en) 1983-10-26
IL67686A0 (en) 1983-05-15

Similar Documents

Publication Publication Date Title
SE8700499D0 (sv) Novel pharmacologically active compounds
EE02962B1 (et) Mometasoonfuroaadi monohüdraat, selle valmistamismeetod ja farmatseutilised kompositsioonid
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
ES8102561A1 (es) Procedimiento de preparacion de los aril-1 arilsulfonil-4 a amino-propoxi-3 1h pirazoles
ES8406448A1 (es) Procedimiento para la preparacion de fenilsulfoniloxibencimidazolcarbamatos sustituidos
IL67686A (en) 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinones,their preparation and pharmaceutical compositions containing them
SE8405588D0 (sv) New compounds
ES8607219A1 (es) Procedimiento para la obtencion de derivados de arilamina
ES475960A1 (es) Procedimiento para la preparacion de 3-di-n-propil-acetoxi- venzodiazepin-2-onas.
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
ES8506710A1 (es) Procedimiento para la obtencion de teofilin-7-acetato de ambroxol
ES8501734A1 (es) Un procedimiento para preparar derivados de cicloalquenilo
JPS51136885A (en) New biologically active substance, ml-236a, and its pr eparation
JPS53119846A (en) Sulfoxide compounds and their preparation
JPS523079A (en) Prepartion of amionuclesides
ATE22288T1 (de) Pyrimidin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische zusammenstellungen.
JPS52136149A (en) 3-epi-xk-88-5 as novel antibiotics and its preparation
JPS5287187A (en) Preparation of 7-alkoxycephalosporin derivatives
NO883545D0 (no) Diethyl-2-(n-(6-fluor-5-methyl-1,2,3,4-tetra-hydrokinaldinyl))-methylenmalonat for anvendelse som utgangsmateriale ved fremstilling av terapeutisk aktive forbindelser.

Legal Events

Date Code Title Description
RH Patent void